Law Courts

Louisiana Attorney General Liz Murrill announced federal lawsuits against New York, California, and Massachusetts for enabling mail-order abortions by refusing to extradite abortionists charged with sending abortion pills into Louisiana, where elective abortion is banned. The state argues that these 'shield' laws violate Louisiana's sovereignty and criminal laws, citing cases where mailed abortion drugs resulted in the deaths of babies and harm to women, and is also challenging the FDA's 2023 policy allowing telehealth prescribing and mail delivery of abortion pills in federal court.

Louisiana Attorney General Liz Murrill, along with Alabama and Arkansas attorneys general, filed two lawsuits targeting abortion pill providers and challenging blue-state shield laws that block prosecution of these providers, with a Supreme Court case against New York, California, and Massachusetts and a separate lawsuit in Louisiana against over 30 individuals and organizations. The complaints allege illegal distribution of abortion pills into states banning abortions, highlight refusal by governors of New York and California to extradite indicted doctors, and describe investigations revealing unsupervised online prescriptions and cases of coerced abortion pill use, while also seeking more federal action and challenging FDA rules on mifepristone dispensing.

Three attorneys general from Louisiana, Alabama, and Arkansas filed a lawsuit with the U.S. Supreme Court challenging abortion shield laws in three Democratic-led states.

Arkansas, Louisiana, and Alabama have filed an original action before the U.S. Supreme Court and a federal lawsuit against New York, California, and Massachusetts to challenge pro-abortion 'shield laws' that protect abortionists mailing abortion drugs to pro-life states.

The attorneys general of Louisiana, Alabama, and Arkansas filed a lawsuit on September 30 challenging the abortion 'shield laws' of New York, California, and Massachusetts, asking the Supreme Court to hear the case. The lawsuit argues that these shield laws protect abortion providers who mail abortion-inducing drugs to states with abortion restrictions, and the case has drawn responses from both sides, including statements from New York Attorney General Letitia James and pro-life leader Marjorie Dannenfelser.

Cases where women were coerced or forced to take abortion pills by their partners, including incidents in Wisconsin and Louisiana, highlighting the ease of obtaining abortion pills online without proper safeguards. It also reports on a federal lawsuit against the FDA and an OB-GYN's test showing that online abortion pill providers do not verify identities or medical conditions, allowing potentially dangerous situations for women to occur.

The Fifth Circuit Court of Appeals recently heard oral arguments in State of Louisiana v. FDA, a case challenging the FDA's policy allowing chemical abortion drugs to be mailed without an in-person medical exam, a policy initiated during the Covid-19 pandemic and continued by both the Biden and Trump administrations.

Novielli reviews oral arguments in Louisiana's challenge to federal rules permitting mailed abortion pills. She describes the state's claims of legal and financial harm and criticism of the federal government's focus on standing.

The Court of Appeals heard oral arguments in Louisiana's lawsuit challenging abortion-pill regulations. Louisiana presented arguments based on state sovereignty and Medicaid costs, seeking specific relief in the case.

The U.S. Fifth Circuit Court of Appeals heard arguments in the Louisiana vs FDA case regarding the FDA's 2023 decision to remove the requirement for an in-person doctor visit before receiving an abortion pill, which Louisiana claims has led to unsafe mailing of abortion pills.

MEDIA ADVISORY: Louisiana v. FDA to be argued in the Fifth Circuit Court of Appeals on September 9, 2026. “Louisiana again confronts the dangers of chemical abortion pills in court, and those risks include threats to endangered species, which we detailed in our amicus brief,” said Students for Life’s Kristan Hawkins. “A peer-reviewed study shows that mifepristone and mifepristone equivalents taint the water where it was tested. The risk to ... Read More The post Students for Life Again Supports Louisiana’s Case Against the FDA with an Amicus Brief, As Chemical Abortion Pill Policy to be Debate

(Washington, D.C.): Last week, Americans United for Life (AUL) signed on to the amicus brief led by Advancing American Freedom in Louisiana v. FDA, which continues to be litigated following the Supreme Court’s decision to reverse the Fifth Circuit’s stay on mail-order abortion regulations last month. Our joint briefing argues that states, including Louisiana, have the authority to regulate […] The post Americans United for Life Joins Advancing American Freedom on Amicus Brief in Louisiana v. FDA appeared first on Americans United for Life .

By Alasdaire FleitasVolunteer Contributor, Save the Storks The Supreme Court cases, Danco Laboratories v Louisiana and GenBioPro v Louisiana, ruled that the manufacturers of the pill used for chemical abortions can continue to mail the drug mifepristone across state lines despite Louisiana’s abortion ban. This ruling comes on the heels of the infamous 2022 Supreme Court case Dobbs v Jackson Women’s Health […] The post Supreme Court Abortion Pill Ruling Expands Access to Mifepristone Nationwide appeared first on Save the Storks .

The Supreme Court may have allowed for the mail distribution of Chemical Abortion Pills, but two of its justices aren’t letting them do it in peace — and they’re practically quoting Students for Life of America’s (SFLA) messaging. On May 14, the Supreme Court decided to allow for the mass telehealth prescription and mail trafficking of Chemical Abortion Pills to continue while Louisiana’s case against the Food and Drug Administration (FDA) for allowing ... Read More The post SCOTUS Justices Thomas and Alito Side with Students for Life: Death-by-Mail Chemical Abortion Pill Trafficking MUST END

The U.S. Supreme Court might be fine with Chemical Abortion Pills being mailed to every home like Amazon packages, but America’s physicians aren’t. In Louisiana’s case against the government allowing the mass-mailing of Chemical Abortion Pills, the Association of American Physicians and Surgeons (AAPS) had filed an amicus brief expressing concern about the abortion industry’s death-by-mail practices. “As a group of physicians, AAPS has a strong interest in defending ... Read More The post Physicians Aren’t Happy About Chemical Abortion Pill Mailing — And You Shouldn’t Be, Either appeared first

Press Release: Louisiana Right to Life Disappointed by Supreme Court Order Allowing Mail-Order Abortion Drug Policy to Continue.

“This is a mistake by the Supreme Court with life-and-death implications, a tragedy for preborn babies and their mothers nationwide. Death-by-Mail – established during the Biden Administration – has continued unchecked by the Trump team to this point. The policy harms preborn babies and their mothers, as dangerous, unregulated pills go to abusers, in unmarked packages, leading to chaos in homes across America,” ... Read More The post Chemical Abortion Pill Pushers & Abusers Win Again as the Supreme Court Allows Reckless Distribution as Louisiana’s Case Proceeds appeared first on Students for L

AAPLOG’s amicus brief in Danco v. Louisiana and GenBioPro v. Louisiana filed May 6th affirms that women deserve real medicine, not a mail-order workaround that benefits only the abortion industry. Urging the Supreme Court to leave the Fifth Circuit’s ruling in place (which would immediately reinstate the in-person dispensing requirement for the abortion drug mifepristone), the brief shows that […] The post AAPLOG Files Amicus Brief in Danco v Louisiana first appeared on AAPLOG - American Association of Pro-life Obstetricians & Gynecologists .

May 11th 2026: The stay reference below has been extended by the U.S. Supreme Court until Thursday May 14th at 5 p.m. EST. May 4th 2026: Following the 5th Circuit Court of Appeals decision on Friday, May 1st, the U.S. Supreme Court granted a seven-day “administrative stay” while the appeal proceeds so that all parties... The post UPDATE: Supreme Court Stays 5th Circuit Decision For Review appeared first on Louisiana Right to Life .

National Right to Life welcomes a Fifth Circuit decision temporarily blocking a federal policy that permits mailed abortion pills without an in-person visit. The organization argues that the Louisiana litigation could restore safeguards it considers important for women and unborn children.

(Washington, D.C.): The U.S. Court of Appeals for the Fifth Circuit has granted a motion to stay the Food and Drug Administration’s (FDA) 2023 Risk Evaluation and Mitigation Strategy (REMS) for mifepristone, which established mail-order access to the abortion drug beginning under the Biden Administration. This stay was granted upon appeal by the plaintiffs, including the State of Louisiana, after the U.S. District Court the Western District of Louisiana granted […] The post Fifth Circuit Grants Stay in Louisiana v. FDA, Blocking Mail-Order Abortion appeared first on Americans United for Life .

Federal Court Affirms Louisiana’s Case on Abortion Pills—But Stops Short of Needed Action From Louisiana Right to Life Staff On April 7, 2026, the U.S. District Court for the Western District of Louisiana (Lafayette Division) issued a significant ruling in the State of Louisiana’s challenge to the FDA’s deregulation of the abortion drug mifepristone. While... The post Federal Court Affirms Case on Abortion Pills—But Stops Short of Needed Action appeared first on Louisiana Right to Life .

SBA Pro-Life America summarizes litigation challenging federal policies that allow abortion drugs to be prescribed and mailed across state lines. The article presents the organization’s legal and safety arguments and explains why the case matters for state abortion laws.

Twenty-one states have joined Louisiana’s lawsuit against the federal government challenging the U.S. Food and Drug Administration’s (FDA’s) relaxation of abortion pill rules, in defiance of the Trump administration’s call for the matter to be indefinitely postponed. Continue Reading at LifeSiteNews >> The post 21 states back Louisiana’s lawsuit against FDA abortion pill rules appeared first on Lozier Institute .

(Washington, D.C.): Earlier today, the Department of Justice under the Trump Administration requested a federal court to pause the case in Louisiana v. FDA and deny the client immediate relief pending the Food and Drug Administration (FDA) review of the abortion pill, mifepristone. There is no public evidence that this review is actively being conducted. Sarah Zagorski, Senior Director of Public Relations & Communications for Americans United for Life […] The post Trump DOJ Asks for Delay in Essential Abortion Pill Case, Pending FDA Review with No Deadline appeared first on Americans United fo